Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Gee

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of the American College of Clinical Pharmacy : JACCP|April 20, 2026
A Scoping Review of Pharmacist-Based Interprofessional Interventions for Management of Cardiovascular-Kidney-Metabolic ConditionsWendy L St Peter, Joshua J Neumiller, Radica Alicic, et al.
Diabetes Care|June 1, 2026
Continuous Glucose Monitoring and Mortality Risk Among U.S. Veterans Receiving Dialysis With DiabetesYoko Narasaki, Kamyar Kalantar-Zadeh, Yaara Zisman-Ilani, et al.
BMJ (Clinical Research Ed.)|May 12, 2021
SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guidelineSheyu Li, Per Olav Vandvik, Lyubov Lytvyn, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 4, 2025
Outcomes in New User Cohorts of SGLT2 Inhibitors or GLP-1 Receptor Agonists with Type 2 Diabetes and Chronic Kidney DiseaseJ Bradley Layton, Ryan Ziemiecki, Catherine B Johannes, et al.
American Heart Journal|June 20, 2026
Lessons Learned from the Feasibility Phase of the REvascularization CHoices Among Under-Represented Groups Evaluation (RECHARGE) Trial ProgramMario Gaudino, Gregg W Stone, John Puskas, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 17, 2024
Clinical Profile and Treatment Adherence in Patients with Type 2 Diabetes and Chronic Kidney Disease Who Initiate an SGLT2 Inhibitor: A Multi-cohort StudyCatherine B Johannes, Ryan Ziemiecki, Manel Pladevall-Vila, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 19, 2025
Clinical Profile and Treatment Patterns in Individuals with Type 2 Diabetes and Chronic Kidney Disease Who Initiate a GLP-1 Receptor Agonist: A Multinational Cohort StudyManel Pladevall-Vila, Ryan Ziemiecki, Catherine B Johannes, et al.
BMJ (Clinical Research Ed.)|March 2, 2021
A living WHO guideline on drugs to prevent covid-19François Lamontagne, Miriam Stegemann, Arnav Agarwal, et al.
BMJ (Clinical Research Ed.)|September 5, 2020
A living WHO guideline on drugs for covid-19Arnav Agarwal, Beverly Hunt, Miriam Stegemann, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of the American College of Clinical Pharmacy : JACCP|April 20, 2026
A Scoping Review of Pharmacist-Based Interprofessional Interventions for Management of Cardiovascular-Kidney-Metabolic ConditionsWendy L St Peter, Joshua J Neumiller, Radica Alicic, et al.
Diabetes Care|June 1, 2026
Continuous Glucose Monitoring and Mortality Risk Among U.S. Veterans Receiving Dialysis With DiabetesYoko Narasaki, Kamyar Kalantar-Zadeh, Yaara Zisman-Ilani, et al.
BMJ (Clinical Research Ed.)|May 12, 2021
SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guidelineSheyu Li, Per Olav Vandvik, Lyubov Lytvyn, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 4, 2025
Outcomes in New User Cohorts of SGLT2 Inhibitors or GLP-1 Receptor Agonists with Type 2 Diabetes and Chronic Kidney DiseaseJ Bradley Layton, Ryan Ziemiecki, Catherine B Johannes, et al.
American Heart Journal|June 20, 2026
Lessons Learned from the Feasibility Phase of the REvascularization CHoices Among Under-Represented Groups Evaluation (RECHARGE) Trial ProgramMario Gaudino, Gregg W Stone, John Puskas, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 17, 2024
Clinical Profile and Treatment Adherence in Patients with Type 2 Diabetes and Chronic Kidney Disease Who Initiate an SGLT2 Inhibitor: A Multi-cohort StudyCatherine B Johannes, Ryan Ziemiecki, Manel Pladevall-Vila, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 19, 2025
Clinical Profile and Treatment Patterns in Individuals with Type 2 Diabetes and Chronic Kidney Disease Who Initiate a GLP-1 Receptor Agonist: A Multinational Cohort StudyManel Pladevall-Vila, Ryan Ziemiecki, Catherine B Johannes, et al.
BMJ (Clinical Research Ed.)|March 2, 2021
A living WHO guideline on drugs to prevent covid-19François Lamontagne, Miriam Stegemann, Arnav Agarwal, et al.
BMJ (Clinical Research Ed.)|September 5, 2020
A living WHO guideline on drugs for covid-19Arnav Agarwal, Beverly Hunt, Miriam Stegemann, et al.
Pageof 2